Sanfilippo Syndrome is a rare autosomal recessive metabolic disorder characterized by severe neurological symptoms.
Name | Description |
---|---|
Progressive dementia | Progressive dementia |
Aggressive behavior | Aggressive behavior |
Hyperactivity | Hyperactivity |
Seizures | Seizures |
When Eliza O'Neill was diagnosed with Sanfilippo Syndrome, her family started their own nonprofit. So far, the Cure Sanfilippo Foundation has raised over $5.5 million to combat the rare genetic disease. Read their story here.
Cecilia, You are too kind. Thank you for your kind words. I am sure there are many experts out there, they have just not found their way here yet. My best to you and Fiorella. In Love, Patty
Thanks God, I found Patty, Jesse s mother as soon as Fiorella my daughter was diagnosticated by MPS III A Sanfilippo s syndrome, same than him, and she is my guide and my hope resources. So, I suggest to name her OUR SANFILIPPO LEADER !!!!!! Also, if anyone has new info about this disorder....thanks a lot,CECILIA
Title | Date | Link |
---|---|---|
Lysogene and Sarepta Therapeutics Announce Dosing of the First Patient in AAVance, a Phase 2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the Treatment of MPS IIIA (Sanfilippo Syndrome Type A) | 02/19/2019 | |
Treatment in Texas: For families of kids with rare diseases, it’s a full-time job to advocate for, raise millions for research | 12/12/2021 | |
A Doctor And Mother's Plea To FDA To Help Save Children With Rare Disease | 01/07/2024 |
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
I would like to share experiences with other parents in the same situation....
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Created by RareshareTeam | Last updated 29 Jul 2018, 03:56 PM
Created by CECILIA | Last updated 3 Nov 2009, 08:24 PM
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITYOur rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.